To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1494239
Sale price1.017,52 €
|
Pancuronium Bromide Related Compound B (15 mg) (1,1'-(17beta-Acetoxy-3alpha-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) |
F0M046 | 41261-71-6 | 1.017,52 € | |
|
USP-1494240
Sale price949,99 €
|
Pancuronium Bromide Related Compound C (15 mg) (1,1'-(3alpha-acetoxy-17beta-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) |
F0M047 | 27115-86-2 | 949,99 € | |
|
USP-1494909
Sale price1.017,52 €
|
Pantoprazole Related Compound A (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole) |
R12470 | 127780-16-9 | 1.017,52 € | |
|
USP-1494910
Sale price1.074,75 €
|
Pantoprazole Related Compound B (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole) |
R103F0 | 102625-64-9 | 1.074,75 € | |
|
USP-1494920
Sale price988,90 €
|
Pantoprazole Related Compound C (20 mg) (5-(difluoromethoxy)-1H-benzimidazole-2-thiol) |
R02640 | 97963-62-7 | 988,90 € | |
|
USP-1494931
Sale price1.106,79 €
|
Pantoprazole Related Compounds D and F Mixture (20 mg) |
R10860 | NA | 1.106,79 € | |
|
USP-1494942
Sale price1.078,18 €
|
Pantoprazole Related Compound E (20 mg) (6,6'-Bis(difluoromethoxy)-2,2'-bis[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H,1'H-5,5'-bibenzimidazole) |
R127H1 | 2115779-15-0 | 1.078,18 € | |
|
USP-1499403
Sale price2.856,83 €
|
Paricalcitol (10 mg) (COLD SHIPMENT REQUIRED) |
R120H0 | 131918-61-1 | 2.856,83 € | |
|
USP-1499414
Sale price632,94 €
|
Paricalcitol Solution (3 mL) (COLD SHIPMENT REQUIRED) |
R263U0 | N/A | 632,94 € | |
|
USP-1500207
Sale price1.221,25 €
|
Paroxetine Related Compound E (50 mg) (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride) |
R180A0 | 1012886-75-7 | 1.221,25 € | |
|
USP-1500230
Sale price1.184,63 €
|
Paroxetine Related Compound B (15 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride) |
R051H0 | N/A | 1.184,63 € | |
|
USP-1500240
Sale price1.054,14 €
|
Paroxetine Related Compound C (30 mg) ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride) |
R098H0 | 130855-30-0 | 1.054,14 € | |
|
USP-1500251
Sale price1.141,13 €
|
Paroxetine Related Compound D (10 mg) ((3RS,4RS)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride); cis-paroxetine hydrochloride |
R12840 | N/A | 1.141,13 € |
